Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Escient initiates phase I/Ib study of EP-547 to treat cholestatic and uremic pruritus

Sep. 16, 2020

Clinuvel begins DNA repair program with Scenesse

Sep. 15, 2020

Topadur begins phase I study of TOP-N53 for wound healing

Sep. 14, 2020

Arcutis accelerates ARQ-151 into phase III trials for the treatment of atopic dermatitis

Sep. 9, 2020

Arena begins phase II trial of etrasimod for moderate to severe alopecia areata

Sep. 2, 2020

Innovent opens phase I study in China with IBI-112 for autoimmune diseases

Sep. 2, 2020

FDA approves Winlevi for acne

Aug. 27, 2020

Novartis details development of best-in-class LTA4 hydrolase inhibitor LYS-006

Aug. 27, 2020

Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical patent JAK-2, TYK2 inhibitors

Aug. 14, 2020

Phase IIa study of KY-1005 in atopic dermatitis meets primary endpoints

Aug. 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...